Gilead Sciences Inc (NASDAQ:GILD)
| 67.23 Delayed Data As of Jun 17 |  -0.11 / -0.16%Today’s Change | 56.56 Today|||52-Week Range 78.94 | +15.40% Year-to-Date |
GILD Regular Dividend: GILD began trading ex-dividend on 06/14/21. A $0.71 dividend will be paid to shareholders of record as of 06/15/21.
Latest GILD News | Press Releases
Today’s Trading
| Previous close | 67.33 |
| Today’s open | 67.32 |
| Day’s range | 66.49 - 67.48 |
| Volume | 7,015,715 |
| Average volume (3 months) | 7,546,019 |
| Market cap | $86.2B |
Data as of 4:00pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | -97.69% |
| Earnings growth (this year) | +0.67% |
| Earnings growth (next 5 years) | +1.29% |
| Revenue growth (last year) | +10.39% |
| P/E ratio | 268.9 |
| Price/Sales | 2.99 |
| Price/Book | 4.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNAModerna Inc | +4.63 | +2.34% |
| ILMNIllumina Inc | +9.94 | +2.23% |
| BIIBBiogen | -7.79 | -1.99% |
| AMGNAmgen | +1.18 | +0.49% |
Data as of 4:00pm ET, 06/17/2021
Financials
| Next reporting date | July 28, 2021 |
| EPS forecast (this quarter) | $1.75 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $123.0M |
| Net profit margin | 0.50% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
